Table of Contents AIHP Contact InformationORDER Symposium Book
	ACADEMIC SYMPOSIUM A uniformed Public Health Service officer and another scientist study infectious diseases in the Division of Pathology and Bacteriology, Hygienic Laboratory (precursor to the National Institutes of Health), 1925. On March 28 and 29, 1996, a group of eminent scientists, historians, and policy analysts gathered at the Carter Center in Atlanta, Georgia, for the Medicines: The Inside Story academic symposium. Participants, who represented a wide variety of institutions, including The Task Force for Child Survival and Development, the Food and Drug Administration, and several American universities, presented twenty peer-reviewed papers that echoed and expanded upon the themes addressed in the innovative Medicines museum exhibition. The symposium presentations, aimed at a general audience, have been published through the American Institute of the History of Pharmacy. The 300 page book includes over twenty papers with related illustrations and is available in both paperback and hardcover editions. The book and symposium were developed under the auspices of the American Institute of the History of Pharmacy. Day One The first day of the symposium looks at drug discovery from both historical and contemporary perspectives. Following the introductory remarks by Glaxo Wellcome President Robert A. Ingram, former United States Surgeon General Dr. C. Everett Koop will deliver the keynote address. The remainder of the morning session lays out a historical framework, providing an overview of medical discoveries up until the early modern era. Papers address such issues as how the ancients chose and used medicines like opium and mandrake. The afternoon session is devoted to case studies of individual drug discovery, with an emphasis on modern breakthroughs. Topics include how Salvarsan was developed as a remedy for syphilis, the isolation of insulin, and the invention of synthetic narcotics. Day Two The symposium's second day is geared towards the practical and policy issues related to medicine making. In the morning session, experts in the fields of medicinal chemistry, pharmacology, pharmacognosy, pharmaceutics, and clinical testing will review current trends and concerns within each of their disciplines. The concluding session examines the process of getting medicines out of the laboratory and into the hands of health-care professionals and patients. This session's panelists include a broad range of individuals involved in various aspects of that process; their presentations cover the development, regulation, and marketing of medicines, as well as the interaction of physicians, pharmacists, and patients. Dr. William Foege, the Executive Director of the Task Force for Child Survival and Development, will deliver a final paper that speaks to the impact of medicines in the global arena.